Triastek’s Co-Development Agreement with Sperogenix Therapeutics

Morrison & Foerster LLP advised Triastek, Inc. on the deal.Triastek, Inc., a leading pharmaceutical company specializing in 3D printing of drug products, announced its co-development agreement…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Sonia Carcano

Author: Sonia Carcano

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here